Skip to main content

Table 1 The results of case detection in each study area of the pilot project

From: Effectiveness of joint 3 + 1 malaria strategy along China–Myanmar cross border areas

Area

Year

Population

No. of blood examination

No. of confirmed or registered cases

Proportion of Pv (%, No.)

ABER (%)

MTPR (%)

API or AIR (‰, 95% CI)

Compared with last year

Compared between 2019 and 2016

X2 (P value)

OR (95% CI)

x2 (P Value)

OR (95% CI)

 + 1

2015

19,470

5361

940

99.36 (934)

27.53

17.53

48.28 (45.27–51.29)

1462.89 (< 0.001)

0.11 (0.09–0.12)

2016

19,583

9275

2080

97.69 (2032)

47.36

22.43

104.77 (100.51–109.03)

442.43 (< 0.001)

2.31 (2.13–2.5)

2017

19,754

8754

1936

98.19 (1901)

44.32

22.12

98.01 (93.86–102.15)

4.97 (0.026)

0.93 (0.87–0.99)

2018

20,560

8095

664

95.63 (535)

39.37

8.20

32.3 (29.88–34.71)

720.97 (< 0.001)

0.31 (0.28–0.34)

2019

18,640

7644

227

100 (227)

41.01

2.97

12.18 (10.6–13.75)

178.13 (< 0.001)

0.37 (0.32–0.43)

The first preventive line

2015

1822

1163

110

100 (110)

63.83

9.46

60.37 (49.43–71.32)

36.84 (< 0.001)

0.33 (0.23–0.48)

2016

1897

1293

100

100 (100)

68.16

7.73

57.63 (46.92–68.34)

0.43 (0.512)

0.91 (0.69–1.21)

2017

2067

1369

119

96.64 (115)

66.23

8.69

57.57 (47.52–67.62)

0.45 (0.504)

1.1 (0.84–1.44)

2018

2097

1424

52

98.08 (51)

67.91

3.65

24.8 (18.14–31.46)

28.39 (< 0.001)

0.42 (0.3–0.58)

2019

2165

1415

39

100 (39)

65.36

2.76

18.01 (12.41–23.62)

2.35 (0.126)

0.72 (0.47–1.1)

The second preventive line

2015

141,107

4989

23

100 (23)

3.54

0.46

0.16 (0.09–0.22)

5.38 (0.020)

0.48 (0.25–0.90)

2016

144,339

5532

30

96.67 (29)

3.83

0.54

0.20 (0.13–0.27)

0.81 (0.368)

1.29 (0.74–2.24)

2017

147,084

5001

22

95.46 (21)

3.40

0.44

0.15 (0.09–0.21)

1.39 (0.239)

0.72 (0.42–1.25)

2018

148,477

5353

18

94.44 (17)

3.61

0.34

0.12 (0.07–0.18)

0.44 (0.508)

0.81 (0.43–1.51)

2019

145,741

4772

14

100 (14)

3.27

0.29

0.1 (0.05–0.15)

0.43 (0.513)

0.79 (0.39–1.59)

The third preventive line

2015

158,872

12,553

42

97.62 (41)

7.90

0.33

0.26 (0.18–0.34)

4.52 (0.033)

0.64 (0.43–0.97)

2016

165,853

13,785

56

96.43 (54)

8.31

0.41

0.34 (0.25–0.43)

1.44 (0.229)

1.28 (0.86–1.91)

2017

160,314

12,395

38

97.37 (37)

7.73

0.31

0.24 (0.16–0.31)

2.86 (0.091)

0.7 (0.46–1.06)

2018

161,782

10,005

35

100 (35)

6.18

0.35

0.22 (0.14–0.29)

0.15 (0.696)

0.91 (0.58–1.44)

2019

179,325

6553

39

100 (39)

3.65

0.60

0.22 (0.15–0.29)

0.001 (0.982)

1.01 (0.64–1.59)

Yingjiang County

2015

301,801

18,705

175

99.43 (174)

6.20

0.94

0.56 (0.48–0.64)

35.82 (< 0.001)

0.47 (0.37–0.61)

2016

312,089

20,610

186

98.39 (183)

6.60

0.90

0.59 (0.51–0.68)

0.29 (0.592)

1.06 (0.86–1.30)

2017

309,465

18,765

179

96.65 (173)

6.06

0.95

0.58 (0.49–0.66)

0.06 (0.815)

0.98 (0.79–1.2)

2018

312,356

16,782

105

98.1 (103)

5.37

0.63

0.34 (0.27–0.4)

19.99 (< 0.001)

0.58 (0.46–0.74)

2019

327,231

12,740

92

100 (92)

3.89

0.72

0.28 (0.22–0.34)

1.57 (0.210)

0.84 (0.63–1.11)

  1. (1) PvPlasmodium vivax; (2) ABER annual blood examination rate; (3) MTPR malaria test positivity rate; (4) API annual parasite incidence; (5) AIR annual importation rate which was calculated after getting rid of the indigenous cases; CI Confidence interval; (6) x2 = chi-square test; (7) OR odds ratio